Treatment response of CNS high‐grade neuroepithelial tumors with MN1 alteration

Authors:

Abstract
Central nervous system high‐grade neuroepithelial tumor with MN1 alteration (CNS HGNET‐MN1) is a rare recently described entity. Fourteen CNS HGNET‐MN1 patients were identified using genome‐wide methylation arrays/RT‐PCR across seven institutions. All patients had surgery (gross total resection: 10; subtotal resection: four) as initial management followed by observation alone in three patients, followed by radiotherapy in eight patients (focal: five; craniospinal: two; CyberKnife: one) and systemic chemotherapy in three patients. Seven patients relapsed; five local and two metastatic, despite adjuvant radiotherapy, of which three died. Treatment of CNS HGNET‐MN1 remains a major treatment challenge despite aggressive surgical resections and upfront radiotherapy, warranting new approaches to this rare malignancy.
All Related Versions

This publication has 11 references indexed in Scilit: